National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 2,116 cases where Vaccine is COVID19 and Symptom is Guillain-Barre syndrome

Government Disclaimer on use of this data



Case Details

This is page 14 out of 212

Result pages: prev   5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23   next


VAERS ID: 1206124 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-03-26
Onset:2021-04-03
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 RA / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Blood test, Guillain-Barre syndrome, Lumbar puncture abnormal, Magnetic resonance imaging
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: A battery of tests while patient was hospitalized from April 5 to April 9th. Spinal tap; MRI, blood etc
CDC Split Type:

Write-up: Patient developed Guilain Barre Syndrome GBS as confirmed by hospital neurologist. Dr felt the Covid 19 vaccination was the likely cause.


VAERS ID: 1207274 (history)  
Form: Version 2.0  
Age: 76.0  
Sex: Male  
Location: Indiana  
Vaccinated:2021-04-01
Onset:2021-04-06
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Computerised tomogram head, Electromyogram, Gait disturbance, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture, Magnetic resonance imaging head, Magnetic resonance imaging neck, Magnetic resonance imaging spinal, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: Amoxicillin Codeine Sildenafil Citrate Simvastatin
Diagnostic Lab Data: Lumar Puncture 04/13/2021 EMG 04/13/2021 MRI Brain 04/12/2021 MRI Cervical 04/12/2021 MRI Lumbar Spine 04/11/2021 CT Head 04/11/2021 EMG IVIG initiated 04/12/2021
CDC Split Type:

Write-up: Per patient and spouse: 2nd dose of Moderna received on 04/01/2021. (This facility does not have record of administration). Patient seen in ED 4/11 after 5 days of bilateral lower extremity weakness, gait problems and numbness. Patient admitted and evaluated. Neurology consulted and on 04/13/2021 diagnosed with likely acute inflammatory demyelinating polyradiculoneuropathic form of Guillain-Barre syndrome.


VAERS ID: 1207752 (history)  
Form: Version 2.0  
Age: 52.0  
Sex: Female  
Location: Michigan  
Vaccinated:2021-03-20
Onset:2021-04-02
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805020 / 1 RA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Back pain, Guillain-Barre syndrome, Hypoaesthesia, Hypoaesthesia oral, Paraesthesia
SMQs:, Peripheral neuropathy (narrow), Retroperitoneal fibrosis (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Symptoms started 4/2/21. Stated as numbness and tingling in lower extremities and progressed to numbness of tongue and upper extremities along with back pain. Patient admitted to Hospital with R/O Guillian Barre Syndrome.


VAERS ID: 1207893 (history)  
Form: Version 2.0  
Age: 43.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-01-27
Onset:2021-03-01
   Days after vaccination:33
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / SYR

Administered by: Private       Purchased by: ?
Symptoms: CSF glucose normal, CSF protein increased, CSF red blood cell count positive, CSF white blood cell count, Electromyogram normal, Guillain-Barre syndrome, Nerve conduction studies abnormal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: levothyroxine 88 mcg (0.088 mg) oral tablet, See Instructions, 11 refills multivitamin, Oral, DAILY Vitamin C, Oral, DAILY Vitamin D3, Oral Zofran 4 mg oral tablet, 4 mg= 1 tab, Oral, Q8HRS, PRN, 2 refills
Current Illness: COVID19 December 2020 by NP swab
Preexisting Conditions: Hypothyroidism
Allergies: NKDA
Diagnostic Lab Data: CSF April 10 2021: WBC Auto Total CSF 2 /mm3 , RBC Auto Total CSF 3 /mm3, Glucose CSF 62 mg/dL, Protein CSF 93 mg/dL NCV EMG April 13 2021 testing revealed abnormal nerve conduction studies because of multiple prolonged motor distal latencies and conduction velocities, with motor conduction block, abnormal temporal dispersion and prolonged or absent F responses. Sensory evoked responses were of decreased amplitude and slowed conduction velocity in the upper extremities. Electromyography was normal.
CDC Split Type:

Write-up: Guillian Barre syndrome: 43-year-old woman with COVID-19 infection in late 2021 followed by two mRNA COVID vaccinations presents with 4-week history of lower extremity paresthesias and 2-week history of lower extremity weakness with diffuse areflexia. CSF protein is elevated, without pleocytosis. This constellation of findings is concerning for Guillain-Barr´┐Ż syndrome.


VAERS ID: 1208095 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Female  
Location: Georgia  
Vaccinated:2021-03-10
Onset:2021-03-13
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM9809 / 1 LA / SYR
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0150 / 2 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Blood test, Guillain-Barre syndrome, Hypoaesthesia, Hypoaesthesia oral, Insomnia, Oral pain, Pain, Pain in extremity, Proctalgia, Weight decreased
SMQs:, Peripheral neuropathy (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: Full panels of blood work have been done twice, first at the ER in early March. Second on 4/12/21 3/2/21 - Gabapentin 300mg - no result 3/23/21 - Amitriptyline 25 MG - No Result 3/26/21 - topiramate 50mg - no result 3/26/21 - bupropion 150mg no result 3/29/21 - Gabba Pentin 800mg - No result 4/9/21 zolpidem 5mg no resulut 4/9/21 pregabalin 75mg no result
CDC Split Type:

Write-up: Doctors believe my wife has developed Gillian-Barre Syndrome as a result of the covid vaccine. We have visited the ER, 2 different Nuerologist, 2 different Internalist, a eye specialist (optometrist) and today the a spine Center. Healthy 35 year old pre vacine, post-first vaccine shot developed numbness and shooting pain in feet, it has spread to fingers, mouth and rectum. Eye prescriptions have changed drastically in last 3 weeks, extreme weight loss (down 20lbs), insomnia


VAERS ID: 1208355 (history)  
Form: Version 2.0  
Age: 64.0  
Sex: Female  
Location: Utah  
Vaccinated:2021-03-04
Onset:2021-04-13
   Days after vaccination:40
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (UNKNOWN)) / UNKNOWN MANUFACTURER - / 1 LA / -

Administered by: Private       Purchased by: ?
Symptoms: Brain scan normal, Guillain-Barre syndrome, Inhalation therapy, Lumbar puncture abnormal, Magnetic resonance imaging thoracic abnormal, Pulmonary embolism
SMQs:, Peripheral neuropathy (narrow), Embolic and thrombotic events, venous (narrow), Guillain-Barre syndrome (narrow), Cardiomyopathy (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Plaquenil, levothyroxin, cymbalta, vit D, lisinopril, omeprizil
Current Illness: Mixed connective tissue Hypothyroid
Preexisting Conditions: Arthritis
Allergies: Codeine. Penicillin latex
Diagnostic Lab Data: Brain scan 3/2021 normal. Chest mri ER, 3/19/2021 admitted Ogden Regional for PE , 3/26/2021 admitted for Guillian Barre Ogden regional , spinal tap confirmed on 3/29/2021, had physical and inhalation therapy in hosp. Home with symptoms 3/30/2021
CDC Split Type:

Write-up: J&J Covid vaccination fine symptoms started 10 days later


VAERS ID: 1208361 (history)  
Form: Version 2.0  
Age: 74.0  
Sex: Male  
Location: New Mexico  
Vaccinated:2021-02-05
Onset:2021-03-02
   Days after vaccination:25
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient was vaccinated on 2/05/2021 with 2nd Pfizer vaccine and was hospitalized for Guillain Barre On 03/11. Has been In hospital since.


VAERS ID: 1208642 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Female  
Location: Mississippi  
Vaccinated:2021-02-24
Onset:2021-02-24
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Computerised tomogram, Guillain-Barre syndrome, Lumbar puncture, Magnetic resonance imaging
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Rheumatoid arthritis
Preexisting Conditions: Rheumatoid arthritis
Allergies: Zucchini
Diagnostic Lab Data: Multiple MRI, CT scan, & lumbar puncture. Best guess diagnosis of GBS at the ER, Clinical diagnosis of GBS confirmed at another Health Center (patient was airlifted due to no capacity at hospitals in the area) and diagnosis confirmed again by Dr., Neurologist at the hospital.
CDC Split Type:

Write-up: Diagnosed as Guillan-Barre?Syndrome


VAERS ID: 1209035 (history)  
Form: Version 2.0  
Age: 82.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-02-15
Onset:2021-03-18
   Days after vaccination:31
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / IM
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 2 - / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Angiogram cerebral normal, Apnoea, Arteriogram carotid normal, Cholecystitis, Dyspnoea, Endotracheal intubation, Gastrostomy, Guillain-Barre syndrome, Haematocrit normal, Haemoglobin normal, Immunoglobulin therapy, Intensive care, Liver function test abnormal, Magnetic resonance imaging head normal, Mental status changes, Miller Fisher syndrome, Platelet count decreased, Respiratory failure, Small intestinal obstruction, Syncope, Tracheostomy, Vomiting, White blood cell count normal
SMQs:, Torsade de pointes/QT prolongation (broad), Liver related investigations, signs and symptoms (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Angioedema (broad), Haematopoietic thrombocytopenia (narrow), Peripheral neuropathy (narrow), Systemic lupus erythematosus (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Dementia (broad), Gastrointestinal obstruction (narrow), Acute central respiratory depression (narrow), Infectious biliary disorders (narrow), Gallbladder related disorders (narrow), Pulmonary hypertension (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Demyelination (narrow), Ocular motility disorders (narrow), Hypotonic-hyporesponsive episode (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Hypokalaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 20 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Problem List/Past Medical History Ongoing : Back pain, Right foot pain Historical No qualifying data
Allergies: NKA
Diagnostic Lab Data: 3/20/21 Hgb 15.2 Hct 45 platelets 134,000. 3/24/21 Hemoglobin 13.2, hematocrit 39.9, white blood cell count 6.9, platelets 153,000. RADIOGRAPHIC STUDIES: MRI scan of the brain on 03/20/2021: No diffusion restriction has developed in the interval to suggest acute infarct. No new abnormalities otherwise noted. MRI of the brain without contrast on 03/19/2021, "No acute intracranial abnormality. No acute infarct. Chronic mild cerebral volume loss and white matter microangiopathic changes." CT angiogram of the head and the neck on 03/19/2021: No acute intracranial abnormality. Major proximal intracranial arteries are patent without stenosis, aneurysm or vascular malformation. Neck carotid and vertebral arteries are normal. No atherosclerotic disease or stenosis.
CDC Split Type:

Write-up: 82YM Admit 3/18/21 to hospital for small bowel obstruction within 1 week of second vaccine dose. PTA bowel obstruction led to a syncopal episode following use of laxative, and several episodes of vomiting in the days prior . Upon admission Patient was receiving conservative therapy for a partial obstruction when he developed increasing shortness of breath. The patient was transferred to the ICU for worsening respiratory status and eventually developed significant hypercapnic and hypoxemic respiratory failure requiring intubation. Neurology was consulted for altered mentation in the setting of respiratory failure. Patient with ascending paralysis. MRI of the head and neck as well as CTA were obtained x2. Patient was ultimately diagnosed with Guillain-Barre, variant and received 5 days of Intravenous Immune Globulin therapy. Patient''s small bowel obstruction resolved and ultimately patient required percutaneous tracheostomy tube and gastrostomy tube placement for prolonged respiratory failure and neurologic compromise. The patient had uneventful ventilatory requirements and ultimately was performing intermittent spontaneous breathing trials; however, still had episodes of apnea, but improved. He was tolerating tube feeds at goal with resolution of his small bowel obstruction, which was thought secondary to his Guillain-Barre. The patient did develop abnormal LFTs which were thought secondary to cholecystitis not requiring operative intervention, with improving LFT findings on antibiotics. The patient had a nonobstructive cholecystitis. The patient''s mentation was improving to the point where he was able to communicate and open his eyes upon discharge, as well as was working with Physical Therapy for strengthening. He was able to move his upper extremities and followed commands and lower extremities were improving in strength as well. Patient was discharged via private air flight to acute care ICU facility.


VAERS ID: 1212716 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Female  
Location: Arizona  
Vaccinated:2021-04-03
Onset:2021-04-09
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Private       Purchased by: ?
Symptoms: Balance disorder, Blood thyroid stimulating hormone normal, CSF glucose normal, CSF protein normal, CSF white blood cell count, Diplopia, Dizziness, Drug screen negative, Dysmetria, Gait disturbance, Guillain-Barre syndrome, Headache, Immunoglobulin therapy, Magnetic resonance imaging head abnormal, Miller Fisher syndrome, Mydriasis, SARS-CoV-2 test negative, Scan with contrast abnormal, Treponema test negative, Vision blurred, Vitamin D decreased
SMQs:, Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Glaucoma (broad), Demyelination (narrow), Lens disorders (broad), Retinal disorders (broad), Vestibular disorders (broad), Ocular motility disorders (narrow), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: 4 day gastrointestinal illness including vomiting, diarrhea, and fever 2 to 3 weeks prior to symptom onset
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: MR Orbit W/+W/O Contrast 04/11/2021 08:57 EXAM: MR Orbit W/+W/O Contrast, MR Brain W + W/O Contrast INDICATION: new onset blurry vision, mydriasis, double vision. COMPARISONS: CT head from 4/10/2021.TECHNIQU E: Multiplanar, multisequence MRI of the brain and orbits was performedbefore and after the uneventful administration of intravenous gadolinium-basedcontrast, dosage below. CONTRAST: 7 mL Gadavist. FINDINGS: BRAIN:Normal parenchymal signal intensity. No diffusion abnormality. No pathologicgradient susceptibility. Normal parenchymal volume and morphology.There is asymmetric enhancement of the right cisternal 6th cranial nerve and thevery proximal left sixth cranial nerve (series 22 image 3) as well as of thecisternal portion of the right 3rd cranial nerve (series 22 image 6). No evidence of hemorrhage. No extra-axial fluid collection. No midline shift.Basal cisterns maintained. Ventricles unremarkable. Central arterial flow voidspreserved.Calvarium unremarkable. Scalp soft tissues normal. ORBITS/FACE:Preseptal soft tissues normal. Globes unremarkable. Extraconal fat preserved.Extraocular muscles normal. There is mildly increased ill-defined hazyenhancement within the intraconal fat of the inferior right orbit, see series 22image 6 and series 21 image 6, only seen on the postcontrast images with noconfirmatory findings on the T1 precontrast or T2 sequences. Lacrimal glandsunremarkable. No abnormality in the region of the lacrimal sac.Optic nerves normal in morphology and signal intensity, no pathologicenhancement. No optic nerve sheath dilatation. Optic chiasm normal. Optic tractsnormal.Remaining facial soft tissues unremarkable. Visualized portions of theaerodigestive tract normal. Normal appearance of the regional vasculature. Novisualized enlarged or morphologically abnormal lymph nodes. Paranasal sinusesnormally aerated. Nasal septum is deviated to the right. Temporal bonestructures unremarkable.IMPRESSION: 1. Isolated enhancement of the right more than left 6th cranial nerves and ofthe right 3rd cranial nerve at the cisternal portions. This is nonspecific andmay be postinfectious or inflammatory. Acute demyelinating process such asMiller Fisher syndrome should also be clinically considered. No brainparenchymal abnormality.2. Subtle hazy enhancement within the intraconal fat of the right orbitinferiorly, which may be artifactual given the absence of abnormal findings onthe precontrast T1 or the T2 sequences, however may imply congestion orinflammation, uncertain etiology. Urine drug screen was obtained and negative. RPR negative. TSH WNL at 3.61. Vitamin D low at 18.6 and started on supplementation. COVID IgG Nonreactive, patient received Pfizer vaccine first dose 1 week prior to admission. Lumbar Puncture obtained on 4/11/21. CSF studies remarkable for elevated protein 45 with normal glucose and normal WBC 1. Multiple sclerosis panel sent on CSF fluid and pending. EBV panel, Mycoplasma serology, Cocci serology, EBV serology, ANA with reflex to Lupus panel, antiGQ1B, anti-GAD, Aquaporin 4, Anti MOG sent and pending.
CDC Split Type:

Write-up: Admitted to hospital on 4/10 with 2 day history of mydriasis, diplopia with blurry vision, dizziness and balance difficulty. Found to have enhancement of 6th and 3rd CNs on MRI. Patient continued to have blurry and double vision during her stay and mild gait instability. She developed mild frontal headache managed with Tylenol. Her exam was remarkable for mydriasis, mild lateral gaze limitation R$gL, mild dysmetria, dizziness and unsteady gait without notable ataxia. No papilledema. Her reflexes were 2+ in her BL UE and LEs. Pediatric Neurology and ophthalmology consulted and followed patient. Eye exam remarkable for bilateral cranial nerve 6 palsy but no other element of CN3 palsy and bilateral dilated but unreactive pupils. Patient treated with IVIG 1mg/kg/day x2 days for likely miller fisher syndrome variant of Guillain-Barre.


Result pages: prev   5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=14&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166